Reports for NOVARTIS PHARMACEUTICALS CANADA INC
Company Name
NOVARTIS PHARMACEUTICALS CANADA INC
Totals |
||
Shortage reports |
148 |
|
| Actual shortage: | 3 (2%) | |
| Anticipated shortage: | 2 (1%) | |
| Avoided shortage: | 4 (3%) | |
| Resolved: | 139 (94%) | |
Discontinuation Reports |
51 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 51 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
34 (17%) |
|
Overdue reports |
1 (20%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DUREZOL | 0.05% | EMULSION | Resolved | 2023-10-23 | 2024-03-06 | 207835 |
| TOBRADEX | 0.1% 0.3% | OINTMENT | Resolved | 2017-06-23 | 2017-07-11 | 13861 |
| TOBRADEX | 0.1% 0.3% | OINTMENT | Resolved | 2017-07-27 | 2017-09-13 | 17414 |
| TOBRADEX | 0.1% 0.3% | OINTMENT | Resolved | 2017-09-18 | 2017-11-02 | 22359 |
| TOBRADEX | 0.1% 0.3% | OINTMENT | Resolved | 2018-12-19 | 2019-02-02 | 70039 |
| TOBRADEX | 0.1% 0.3% | SUSPENSION | Resolved | 2017-09-05 | 2017-09-14 | 20969 |
| TOBRADEX | 0.1% 0.3% | SUSPENSION | Resolved | 2022-07-21 | 2022-08-06 | 165184 |
| VOLTAREN OPHTHA | 0.1% | SOLUTION | Resolved | 2017-11-30 | 2018-01-18 | 31276 |
| VOLTAREN OPHTHA | 0.1% | SOLUTION | Resolved | 2018-03-26 | 2018-12-11 | 44015 |
| VOLTAREN OPHTHA | 0.1% | SOLUTION | Resolved | 2018-03-26 | 2018-06-22 | 44018 |
| VOLTAREN OPHTHA | 0.1% | SOLUTION | Avoided shortage | 2019-01-08 | 2019-04-29 | 71606 |
| VOLTAREN OPHTHA | 0.1% | SOLUTION | Resolved | 2020-09-08 | 2020-10-08 | 123880 |
| VOLTAREN OPHTHA | 0.1% | SOLUTION | Resolved | 2020-12-10 | 2021-01-20 | 130021 |
| VOLTAREN OPHTHA | 0.1% | SOLUTION | Resolved | 2023-05-19 | 2023-09-27 | 192835 |
| VOLTAREN OPHTHA | 0.1% | SOLUTION | Resolved | 2023-09-27 | 2024-02-03 | 205330 |
| ALOMIDE | 0.1% | SOLUTION | Resolved | 2018-06-01 | 2018-06-19 | 51063 |
| ALOMIDE | 0.1% | SOLUTION | Resolved | 2018-06-22 | 2018-07-27 | 52770 |
| ALOMIDE | 0.1% | SOLUTION | Resolved | 2018-08-15 | 2018-10-18 | 58228 |
| ALOMIDE | 0.1% | SOLUTION | Resolved | 2020-04-20 | 2020-09-08 | 112537 |
| ALOMIDE | 0.1% | SOLUTION | Resolved | 2022-09-29 | 2022-10-28 | 170488 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| LOPRESOR 50MG | 50MG | TABLET | Discontinued | 2019-04-05 | 2019-04-05 | 80614 |
| VOLTAREN | 50MG | TABLET (DELAYED-RELEASE) | Discontinued | 2020-01-08 | 2020-03-10 | 102699 |
| TASIGNA | 50MG | CAPSULE | Discontinued | 2023-10-19 | 2023-11-06 | 207564 |
| LOTENSIN 5MG | 5MG | TABLET | Discontinued | 2017-07-10 | 2017-09-26 | 15053 |
| SEBIVO | 600MG | TABLET | Discontinued | 2019-07-10 | 2019-11-06 | 89042 |
| AFINITOR | 7.5MG | TABLET | Discontinued | 2018-07-09 | 2018-07-10 | 54891 |
| ONBREZ BREEZHALER | 75MCG | CAPSULE | Discontinued | 2022-06-29 | 2022-07-14 | 163678 |
| ONBREZ BREEZHALER | 75MCG | CAPSULE | Discontinued | 2022-06-29 | 2022-07-14 | 163682 |
| VOLTAREN SR | 75MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-07-10 | 2019-09-06 | 89039 |
| LESCOL XL | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-03-20 | 2020-04-17 | 109153 |
| ZOFRAN | 8MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189538 |